Clinical Trials
304
Active:5
Completed:51
Trial Phases
6 Phases
Early Phase 1:10
Phase 1:5
Phase 2:13
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (176 trials with phase data)• Click on a phase to view related trials
Not Applicable
122 (69.3%)Phase 4
22 (12.5%)Phase 2
13 (7.4%)Early Phase 1
10 (5.7%)Phase 1
5 (2.8%)Phase 3
4 (2.3%)Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine
Not Applicable
Not yet recruiting
- Conditions
- Migraine DisordersPatent Foramen OvaleRight-to-Left Shunt, Cardiac
- First Posted Date
- 2025-09-12
- Last Posted Date
- 2025-09-12
- Target Recruit Count
- 150
- Registration Number
- NCT07170176
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
Not Applicable
Not yet recruiting
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)Burkitt Lymphoma
- Interventions
- Drug: Conditioning chemotherapy followed by AbTCR (anti-CD19/CD22)-T cell infusion
- First Posted Date
- 2025-09-11
- Last Posted Date
- 2025-09-17
- Target Recruit Count
- 3
- Registration Number
- NCT07168291
- Locations
- 🇨🇳
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Early Detection of PDAC in Patients With Chronic Pancreatitis
Completed
- Conditions
- Chronic PancreatitisPDAC - Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Target Recruit Count
- 359
- Registration Number
- NCT07104864
- Locations
- 🇨🇳
the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Recruiting
- Conditions
- Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
- Interventions
- Drug: Peg IFN-α-2b
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Target Recruit Count
- 1500
- Registration Number
- NCT07079150
- Locations
- 🇨🇳
First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an
Not yet recruiting
- Conditions
- HCV InfectionHCV Elimination
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 200000
- Registration Number
- NCT06952036
- Prev
- 1
- 2
- 3
- 4
- 5
- 60
- Next
News
No news found